346 related articles for article (PubMed ID: 30173567)
21. Advancement in stimuli triggered in situ gelling delivery for local and systemic route.
Ajazuddin ; Alexander A; Khan J; Giri TK; Tripathi DK; Saraf S; Saraf S
Expert Opin Drug Deliv; 2012 Dec; 9(12):1573-92. PubMed ID: 23075325
[TBL] [Abstract][Full Text] [Related]
22. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide.
Yuan Y; Cui Y; Zhang L; Zhu HP; Guo YS; Zhong B; Hu X; Zhang L; Wang XH; Chen L
Int J Pharm; 2012 Jul; 430(1-2):114-9. PubMed ID: 22503953
[TBL] [Abstract][Full Text] [Related]
23. In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery.
Al Khateb K; Ozhmukhametova EK; Mussin MN; Seilkhanov SK; Rakhypbekov TK; Lau WM; Khutoryanskiy VV
Int J Pharm; 2016 Apr; 502(1-2):70-9. PubMed ID: 26899977
[TBL] [Abstract][Full Text] [Related]
24. Mucoadhesive In Situ Gelling Liquid Crystalline Precursor System to Improve the Vaginal Administration of Drugs.
de Araújo PR; Calixto GMF; da Silva IC; de Paula Zago LH; Oshiro Junior JA; Pavan FR; Ribeiro AO; Fontana CR; Chorilli M
AAPS PharmSciTech; 2019 Jun; 20(6):225. PubMed ID: 31214798
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in functionally modified polymers for mucoadhesive drug delivery.
Surendranath M; M R R; Parameswaran R
J Mater Chem B; 2022 Aug; 10(31):5913-5924. PubMed ID: 35880449
[TBL] [Abstract][Full Text] [Related]
26. In situ gelling and mucoadhesive polymer vehicles for controlled intranasal delivery of plasmid DNA.
Park JS; Oh YK; Yoon H; Kim JM; Kim CK
J Biomed Mater Res; 2002 Jan; 59(1):144-51. PubMed ID: 11745547
[TBL] [Abstract][Full Text] [Related]
27. Mucoadhesive drug delivery systems: a promising non-invasive approach to bioavailability enhancement. Part I: biophysical considerations.
Kulkarni R; Fanse S; Burgess DJ
Expert Opin Drug Deliv; 2023 Mar; 20(3):395-412. PubMed ID: 36803111
[TBL] [Abstract][Full Text] [Related]
28. Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents.
Serra L; Doménech J; Peppas NA
Eur J Pharm Biopharm; 2009 Mar; 71(3):519-28. PubMed ID: 18976706
[TBL] [Abstract][Full Text] [Related]
29. Drug delivery to the brain: In situ gelling formulation enhances carbamazepine diffusion through nasal mucosa models with mucin.
Corazza E; di Cagno MP; Bauer-Brandl A; Abruzzo A; Cerchiara T; Bigucci F; Luppi B
Eur J Pharm Sci; 2022 Dec; 179():106294. PubMed ID: 36116696
[TBL] [Abstract][Full Text] [Related]
30. Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum.
Ryu JM; Chung SJ; Lee MH; Kim CK; ShimCK
J Control Release; 1999 May; 59(2):163-72. PubMed ID: 10332051
[TBL] [Abstract][Full Text] [Related]
31. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
32. Fabrication of Mucoadhesive-Dendrimers as Solid Dosage Forms.
Raval N; Maheshwari R; Kalia K; Tekade RK
Methods Mol Biol; 2019; 2000():93-109. PubMed ID: 31148012
[TBL] [Abstract][Full Text] [Related]
33. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
Mura P; Mennini N; Nativi C; Richichi B
Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic potential of mucoadhesive drug delivery systems--an updated patent review.
Maurya SK; Pathak K; Bali V
Recent Pat Drug Deliv Formul; 2010 Nov; 4(3):256-65. PubMed ID: 20649509
[TBL] [Abstract][Full Text] [Related]
35. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.
Pandey P; Cabot PJ; Wallwork B; Panizza BJ; Parekh HS
Eur J Pharm Sci; 2017 Jan; 96():499-507. PubMed ID: 27771516
[TBL] [Abstract][Full Text] [Related]
36. Strategies to prolong the residence time of drug delivery systems on ocular surface.
Grassiri B; Zambito Y; Bernkop-Schnürch A
Adv Colloid Interface Sci; 2021 Feb; 288():102342. PubMed ID: 33444845
[TBL] [Abstract][Full Text] [Related]
37. Advances in mucoadhesion and mucoadhesive polymers.
Khutoryanskiy VV
Macromol Biosci; 2011 Jun; 11(6):748-64. PubMed ID: 21188688
[TBL] [Abstract][Full Text] [Related]
38. Vaginal mucoadhesive drug delivery systems.
de Araújo Pereira RR; Bruschi ML
Drug Dev Ind Pharm; 2012 Jun; 38(6):643-52. PubMed ID: 21999572
[TBL] [Abstract][Full Text] [Related]
39. The application of mucoadhesive polymers in nasal drug delivery.
Jiang L; Gao L; Wang X; Tang L; Ma J
Drug Dev Ind Pharm; 2010 Mar; 36(3):323-36. PubMed ID: 19735210
[TBL] [Abstract][Full Text] [Related]
40. An overview of recent patents on composition of mucoadhesive drug delivery systems.
Bruschi ML; de Francisco LM; S de Toledo Lde A; Borghi FB
Recent Pat Drug Deliv Formul; 2015; 9(1):79-87. PubMed ID: 25420876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
